$Combined transepicardial and transseptal implantation of autologous CD 133+ bone marrow cells during bypass grafting improves cardiac function in patients with low ejection fraction$

Combined transepicardial and transseptal implantation of autologous CD 133+ bone marrow cells during bypass grafting improves cardiac function in patients with low ejection fraction

Objectives Autologous CD133+ bone marrow stem cells may improve cardiac function. This randomized, single‐blind clinical trial inquired whether a combined transepicardial and transseptal implantation of CD133+ stem cells during coronary artery bypass grafting (CABG) improve cardiac function with eje...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of cardiac surgery 2020-04, Vol.35 (4), p.740-746
Hauptverfasser:	Soetisna, Tri Wisesa, Sukmawan, Renan, Setianto, Budhi, Mansyur, Muchtaruddin, Murni, Tri Wahyu, Listiyaningsih, Erlin, Santoso, Anwar
Format:	Artikel
Sprache:	eng
Schlagworte:	coronary artery bypass graft coronary artery disease heart failure Original stem cell
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!